Point-of-Care Diagnostics Market to Reach $31.46 Billion by 2031

The global Point-of-Care (POC) Diagnostics market is projected to grow from an estimated $20.63 billion in 2026 to $31.46 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.8%, according to a new report by MarketsandMarkets.

The expansion is driven by the rising global burden of chronic diseases such as diabetes, cardiovascular conditions, and infectious diseases, which necessitate rapid and accurate diagnostics. The increasing demand for decentralized healthcare and faster clinical decision-making further fuels market growth.

In 2025, glucose monitoring products represented the largest market segment, accounting for 34.8% of the total. The home care and self-testing segment held a value of $6,936.5 million in the same year. China is expected to exhibit the highest CAGR during the forecast period, at 11.1%.

The adoption of POC diagnostics spans various settings, including hospitals, emergency departments, physician offices, retail clinics, pharmacies, and home healthcare. Technological advancements and a growing emphasis on early disease detection and personalized medicine are expected to continue driving market expansion.